Juliette Erickson, MD
Hospice and Palliative Medicine · Olympia, WANPI 1851489660
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Among hospice and palliative medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 68 payments — averaging $16.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$190
- Sanofi-aventis U.S. LLC$106
- Bayer$101
- Lilly USA, LLC$96
- Dexcom, Inc.$78
- Novartis$67
- plus $510 from 16 others
What the payments were for
- Food & beverage$1,148100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 10 | $190 |
| Sanofi-aventis U.S. LLC | 6 | $106 |
| Bayer | 6 | $101 |
| Lilly USA, LLC | 6 | $96 |
| Dexcom, Inc. | 6 | $78 |
| Novartis | 4 | $67 |
| Sanofi Pasteur Inc. | 3 | $62 |
| AstraZeneca | 4 | $57 |
| Boehringer Ingelheim | 3 | $57 |
| Pfizer | 3 | $47 |
| Arbor Pharmaceuticals, Inc. | 3 | $45 |
| Mylan Specialty L.p. | 2 | $32 |
| Johnson & Johnson | 1 | $32 |
| Merck | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Sunovion Pharmaceuticals Inc. | 1 | $17 |
| GSK | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $15 |
How this compares
$1,148 in reported general payments places this provider in the 90th percentile of 28 hospice and palliative medicine providers in Washington.
See all hospice and palliative medicine providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 12 | $1,317 |
| Oxycodone Hcl | 19 | $321 |
| Lorazepam | 13 | $51 |
Paid to pharmacies, not to this prescriber.
Other hospice and palliative medicine in Olympia
- Amy PiconeOlympia$14
- Clive LiuRenton$2K
- Joshua RussellLongview$1K
- Luke O'NeillUniversity Place$586
- Karen KastingSeattle$408
- Justin WoodsSpokane$233
- Manpreet SranRedmond$162
- Sunil AggarwalSeattle$160
- Jane YehBellevue$150
- Vanessa HerringSeattle$118
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.